Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors

Dominique S. Meyer, Heike Brinkhaus, Urs Müller, Matthias Müller, Robert Cardiff, Mohamed Bentires-Alj

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

The phosphoinositide 3-kinase (PI3K) signaling cascade, a key mediator of cellular survival, growth, and metabolism, is frequently altered in human cancer. Activating mutations in PIK3CA, which encodes the a-catalytic subunit of PI3K, occur in approximately 30% of breast cancers. These mutations result in constitutive activity of the enzyme and are oncogenic, but it is not known whether they are sufficient to induce mammary carcinomas in mice. In the present study, we show that the expression of mutant PIK3CA H1047R in the luminal mammary epithelium evokes heterogeneous tumors that express luminal and basal markers and are positive for the estrogen receptor. Our results suggest that the PIK3CA H1047R oncogene targets a multipotent progenitor cell and, furthermore, show that this model recapitulates features of human breast tumors with PIK3CA H1047R.

Original languageEnglish (US)
Pages (from-to)4344-4351
Number of pages8
JournalCancer Research
Volume71
Issue number13
DOIs
StatePublished - Jul 1 2011

Fingerprint

Human Mammary Glands
1-Phosphatidylinositol 4-Kinase
Breast Neoplasms
Neoplasms
Mutation
Oncogenes
Estrogen Receptors
Catalytic Domain
Breast
Stem Cells
Epithelium
Survival
Enzymes
Growth

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. / Meyer, Dominique S.; Brinkhaus, Heike; Müller, Urs; Müller, Matthias; Cardiff, Robert; Bentires-Alj, Mohamed.

In: Cancer Research, Vol. 71, No. 13, 01.07.2011, p. 4344-4351.

Research output: Contribution to journalArticle

Meyer, DS, Brinkhaus, H, Müller, U, Müller, M, Cardiff, R & Bentires-Alj, M 2011, 'Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors', Cancer Research, vol. 71, no. 13, pp. 4344-4351. https://doi.org/10.1158/0008-5472.CAN-10-3827
Meyer, Dominique S. ; Brinkhaus, Heike ; Müller, Urs ; Müller, Matthias ; Cardiff, Robert ; Bentires-Alj, Mohamed. / Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. In: Cancer Research. 2011 ; Vol. 71, No. 13. pp. 4344-4351.
@article{de5b005f823e48ab8d702b5d89e3f53c,
title = "Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors",
abstract = "The phosphoinositide 3-kinase (PI3K) signaling cascade, a key mediator of cellular survival, growth, and metabolism, is frequently altered in human cancer. Activating mutations in PIK3CA, which encodes the a-catalytic subunit of PI3K, occur in approximately 30{\%} of breast cancers. These mutations result in constitutive activity of the enzyme and are oncogenic, but it is not known whether they are sufficient to induce mammary carcinomas in mice. In the present study, we show that the expression of mutant PIK3CA H1047R in the luminal mammary epithelium evokes heterogeneous tumors that express luminal and basal markers and are positive for the estrogen receptor. Our results suggest that the PIK3CA H1047R oncogene targets a multipotent progenitor cell and, furthermore, show that this model recapitulates features of human breast tumors with PIK3CA H1047R.",
author = "Meyer, {Dominique S.} and Heike Brinkhaus and Urs M{\"u}ller and Matthias M{\"u}ller and Robert Cardiff and Mohamed Bentires-Alj",
year = "2011",
month = "7",
day = "1",
doi = "10.1158/0008-5472.CAN-10-3827",
language = "English (US)",
volume = "71",
pages = "4344--4351",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors

AU - Meyer, Dominique S.

AU - Brinkhaus, Heike

AU - Müller, Urs

AU - Müller, Matthias

AU - Cardiff, Robert

AU - Bentires-Alj, Mohamed

PY - 2011/7/1

Y1 - 2011/7/1

N2 - The phosphoinositide 3-kinase (PI3K) signaling cascade, a key mediator of cellular survival, growth, and metabolism, is frequently altered in human cancer. Activating mutations in PIK3CA, which encodes the a-catalytic subunit of PI3K, occur in approximately 30% of breast cancers. These mutations result in constitutive activity of the enzyme and are oncogenic, but it is not known whether they are sufficient to induce mammary carcinomas in mice. In the present study, we show that the expression of mutant PIK3CA H1047R in the luminal mammary epithelium evokes heterogeneous tumors that express luminal and basal markers and are positive for the estrogen receptor. Our results suggest that the PIK3CA H1047R oncogene targets a multipotent progenitor cell and, furthermore, show that this model recapitulates features of human breast tumors with PIK3CA H1047R.

AB - The phosphoinositide 3-kinase (PI3K) signaling cascade, a key mediator of cellular survival, growth, and metabolism, is frequently altered in human cancer. Activating mutations in PIK3CA, which encodes the a-catalytic subunit of PI3K, occur in approximately 30% of breast cancers. These mutations result in constitutive activity of the enzyme and are oncogenic, but it is not known whether they are sufficient to induce mammary carcinomas in mice. In the present study, we show that the expression of mutant PIK3CA H1047R in the luminal mammary epithelium evokes heterogeneous tumors that express luminal and basal markers and are positive for the estrogen receptor. Our results suggest that the PIK3CA H1047R oncogene targets a multipotent progenitor cell and, furthermore, show that this model recapitulates features of human breast tumors with PIK3CA H1047R.

UR - http://www.scopus.com/inward/record.url?scp=79959860167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959860167&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-3827

DO - 10.1158/0008-5472.CAN-10-3827

M3 - Article

C2 - 21482677

AN - SCOPUS:79959860167

VL - 71

SP - 4344

EP - 4351

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 13

ER -